Orange Book product · Brand (NDA)
OMEPRAZOLE
OMEPRAZOLE
At a glance
Jul 05, 2017
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 05, 2017
9 yr 1 mo ago
Today
Patent 10076494 expires
Listed drug product patent expiration.
Dec 08, 2036
in 10 yr 8 mo
Patent 10835488 expires
Listed drug product patent expiration.
Dec 08, 2036
in 10 yr 8 mo
Pharmaceutical detail
Active ingredient
OMEPRAZOLE
Strength
20MG
Dosage form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 209400
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2007OMEPRAZOLEBrand (NDA)
NDA 022032 · DEXCEL PHARMA
- 1995PRILOSECBrand (NDA)
NDA 019810 · ASTRAZENECA
- 2020OMEPRAZOLEGeneric (ANDA)
ANDA 212977 · XIROMED
- 2019OMEPRAZOLEGeneric (ANDA)
ANDA 204012 · HETERO LABS LTD III
- 2019OMEPRAZOLEGeneric (ANDA)
ANDA 210070 · APOTEX
- 2018OMEPRAZOLEGeneric (ANDA)
ANDA 207740 · DR REDDYS
- 2018OMEPRAZOLEGeneric (ANDA)
ANDA 207891 · SUN PHARM
- 2018OMEPRAZOLEGeneric (ANDA)
ANDA 205070 · PHARMOBEDIENT
- 2017OMEPRAZOLEGeneric (ANDA)
ANDA 203481 · BRECKENRIDGE
- 2017OMEPRAZOLEGeneric (ANDA)
ANDA 204661 · TEVA PHARMS USA
- 2015OMEPRAZOLEGeneric (ANDA)
ANDA 202384 · LUPIN
- 2015OMEPRAZOLEGeneric (ANDA)
ANDA 203270 · AUROBINDO PHARMA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10076494 | Dec 08, 2036 | in 10 yr 8 mo | Product |
| 10835488 | Dec 08, 2036 | in 10 yr 8 mo | Product |

